Viewing Study NCT02100956


Ignite Creation Date: 2025-12-24 @ 11:38 PM
Ignite Modification Date: 2025-12-25 @ 9:28 PM
Study NCT ID: NCT02100956
Status: TERMINATED
Last Update Posted: 2023-10-03
First Post: 2014-03-27
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Efficacy of Intrathecal Oxytocin in Patients With Neuropathic Pain
Sponsor: Wake Forest University Health Sciences
Organization:

Study Overview

Official Title: Efficacy of Intrathecal Oxytocin in Patients With Neuropathic Pain
Status: TERMINATED
Status Verified Date: 2022-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Cessation of funding period prior to completion, due to slow recruitment during the pandemic
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of the study is to determine the effect of oxytocin given into the spinal fluid on pain and areas and intensity of hyperalgesia and allodynia in patients with chronic neuropathic pain.
Detailed Description: Rationale: The investigators anticipate that oxytocin will be effective after spinal injection in humans to acutely relieve chronic neuropathic pain.

Objectives: Determine the effect of intrathecal oxytocin on pain and areas and intensity of hyperalgesia and allodynia in patients with chronic neuropathic pain.

Interventions: A computer generated randomization will be used to determine the group for each subject. Subjects will be randomized to receive an intrathecal injection of saline (placebo) or oxytocin.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: True
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: